• Non ci sono risultati.

COVID-19: GLI EUROPEI CHIEDONO CERTEZZE SU EFFICACIA E SICUREZZA DEL VACCINO. RICHIESTE PIÙ INFORMAZIONI

N/A
N/A
Protected

Academic year: 2022

Condividi "COVID-19: GLI EUROPEI CHIEDONO CERTEZZE SU EFFICACIA E SICUREZZA DEL VACCINO. RICHIESTE PIÙ INFORMAZIONI"

Copied!
23
0
0

Testo completo

(1)

Public opinion on

Covid-19 vaccination in the EU

Desk Research December 2020

Public opinion on

Covid-19 vaccination in the EU

Desk Research

December 2020

(2)

1. Attitudes to vaccination

(3)

Close to three Europeans in ten would like to get vaccinated «some time in 2021»

(29%); close to one quarter would like to do so «as soon as possible» (23%) and less than a fifth is willing to do it «later» (18%) or «never» (17%)

Q1 If a vaccine against COVID-19 (coronavirus) is authorised by public authorities and available for you, when would you like to get vaccinated?

(% - EU)

As soon as possible 23

Some time in 2021 29

Later 18 Never

17

Don't know 13

3

(4)

More than a third would like to get vaccinated as soon as possible in Malta (41%), Ireland (37%) and Denmark (35%), while at least a third declare that they would never get vaccinated in Bulgaria (34%) and Slovenia (33%)

(5)

Most respondents would be more eager to get vaccinated against COVID-19 if some people have already done so, they see that it works and there are no side-effects (44%) and if there is a full clarity on how vaccines are being developed, tested and authorised (36%)

5

(6)

The fact that some people have already been vaccinated, that the vaccine works and there are no side-effects is the most mentioned answer (or joint most mentioned) in all countries except Portugal and Poland

Q2 Which of the following statements correspond to what you think? You would be more eager to get vaccinated against COVID-19 if… Please tick all answers that apply. (MULTIPLE ANSWERS POSSIBLE)

(% - THE MOST MENTIONED ANSWER BY COUNTRY)

62 59 57

54 54

52 52 51 51 50 50

48 45 45 44

42 42

40 40 40 40 39

37 37 37 34

48 38

FI LT CY EL ES LU AT DK DE SE LV EE MT SI EU27 SK HR IE IT NL RO BE HU CZ BG FR PT PL Some people have already been vaccinated and we see that it works and that there are no side-effects

There is full clarity on how vaccines are being developed, tested and authorised

(7)

More than three quarters agree that some categories of the population should get vaccinated first (76%) and that serious diseases have disappeared thanks to vaccines (76%)

7

(8)

Close to nine in ten in Malta (87%) and more than three quarters in Ireland, Cyprus, Portugal (all 77%) and Luxembourg (76%) agree that the EU is playing a key role in ensuring an access to COVID-19 vaccines in their countries

(9)

Τhe level of agreement that the EU is playing a key role in ensuring that we can have access to COVID-19 vaccines in their countries is less widespread in a group of Central European countries including Czechia (49%), Poland (55%), Hungary (55%) and Slovakia (54%)

9

(10)

In 24 Member States, respondents agree that public authorities are not sufficiently transparent about COVID-19 vaccines

(11)

At least six in ten agree that COVID-19 vaccines are being developed, tested and authorised too quickly to be safe in 19 countries led by Bulgaria (76%), Latvia and Hungary (both 72%)

11

(12)

In 22 Member States led by Denmark (73%), Ireland and Spain (both 71%), a majority agree that a vaccine is the only way to end the pandemic

(13)

Respondents in Southern Europe and Ireland are the ones who fear the most of being infected with the desease

13

(14)

Respondents in Malta, Portugal, Spain and Italy are the most worried about a possible infection

(15)

2. General satisfaction with EU measures to

fight the pandemic

(16)

Respondents are divided on the satisfaction with the way the EU has responded to the COVID-19 pandemic

SD3 Thinking about the way the European Union has responded to the COVID-19 pandemic, would you say that you are...

(% - EU)

Very satisfied 5

Fairly satisfied 39

Fairly dissatisfied 30

Not satisfied at all 15

Don't know 11

Total

‘satisfied’

44%

Total

‘not satisfied’

45%

(17)

In 14 Member States, a majority of respondents are dissatisfied with the way the EU has responded to the COVID-19; in 12 a majority are satisfied, while respondents in Italy are equally divided on this matter (47%)

17

(18)

3. Information on Covid-19

(19)

A clear majority of respondents (55%) trust more health professionals, doctors, nurses and pharmacists to give them reliable information on COVID-19 vaccines, closely followed by the national health authorities (43%)

19

(20)

In 23 Member States, most respondents trust more health professionals, doctors, nurses and pharmacists, while in Nordic countries and Malta, they tend to trust more their national health authorities

Q4 Among the following sources, which ones would you trust more to give you reliable information on COVID-19 vaccines? (MULTIPLE ANSWERS POSSIBLE)

(% - THE MOST MENTIONED ANSWER BY COUNTRY)

76

66 64 64

62 62 61 61 61 60

56 55 55 55 54 54 54 53 52 52

49 47 45 41

66 65

62 62

LU EL ES CY IE PT EE LT SI AT BE EU27 FR NL IT LV BG DE CZ SK RO HU HR PL DK FI SE MT Health professionals, doctors, nurses and pharmacists The (NATIONALITY) health authorities

(21)

A clear majority of respondents would like to get more information on how safe COVID-19 vaccines will be (57%) and one in two on how effective COVID-19 vaccines will be (50%)

21

(22)

In all EU Member States, the most mentioned topic on which respondents would like to get more information is how safe COVID-19 vaccines will be

Q5 On which topics would you like to get more information? (MULTIPLE ANSWERS POSSIBLE) (% - THE MOST MENTIONED ANSWER BY COUNTRY)

76 74 73

70 70 69 69

63 63 62 62 62 61 60 60 60

58 58 58 58 57 56 55 55 55

53 53 51

CY EE EL LU LV LT BG FI SE ES PT SI RO IE IT MT DK HU SK HR EU27 AT BE NL CZ FR PL DE How safe COVID-19 vaccines will be

(23)

METHODOLOGY

Desk research on Public opinion on Covid-19 vaccination in the EU – Fieldwork:

10/12 – 19/12/2020

Population: aged 16-54 in 10 countries, 16-64 in 16 countries and 16+ in Malta

Coverage: 27 EU Member States, national samples representative of the population of each country aged 16-64 years

Method: online, using online access panels in 26 out of 27 EU Member States and telephone in Malta

Number of interviews: 24 424

EU total: weighted according to the size of the population of each country

Survey requested by the European Commission (DG COMM.A3)

23

Riferimenti

Documenti correlati

Department of Medicine, Anesthesia and Intensive Care Clinic, University of Udine, Udine, Italy (L.V., T.B., D.O.) Department of Anesthesia and Intensive Care, University Hospital

Current understanding, based on the noticeable, small, truly congenital nevi and nevi acquired early in life, is that the first develops before puberty, presents with a

La tradizione cui Gregorio di Tours si rifaceva era del tutto indipendente dal racconto di Jordanes: non attribuiva infatti ai Goti il ruolo decisivo che essi

In [41, 42] in- clusive electron scattering data from various nuclei were analyzed in terms of “superscaling”: it was shown that, for energy loss below the quasielastic peak,

The following non-mutually exclusive approaches for vaccine deployment can be considered when building vaccination strategies, taking into account different levels of vaccine

C’est dans ce cadre que l’Initiative de communication pour le développement durable (ICDD), s’est joint au projet REAFOR pour la formulation et la mise en œuvre

At the time for this project/work two stone monuments were examined: the Elephant of Castelsardo (Anglona, north Sardinia) and the Mushroom of Carloforte (north of San Pietro

Inoltre, il primo Francisco de Vargas, quello citato nell’ambito dell’ipotesi del Marìas, si trova a ricoprire la funzione di alcaide (dal 1518) pres- so l’Alcàzar della